|

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

RECRUITINGN/ASponsored by St Vincent's Hospital, Sydney
Actively Recruiting
PhaseN/A
SponsorSt Vincent's Hospital, Sydney
Started2025-12-01
Est. completion2026-05-30
Eligibility
Age18 Years+
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07552922

Summary

This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.

Eligibility

Age: 18 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Men with high-risk BCR PCa but no ADT+/-ARPI experience.
* Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.

Exclusion Criteria:

• Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.

Conditions3

Breast CancerCancerProstate Cancer (Adenocarcinoma)

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.